Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMWP
3001
DELISTED
Eros Media World PLC
EMWP
| $1.46M | ﹤0.01% |
23,109
+710
| +3% | +$40.1K |
|
3002
First Bank
FRBA
$471M
| $1.46M | ﹤0.01% |
223,452
+9,787
| +5% | +$69.2K |
|
3003
Princeton Bancorp
BPRN
$286M
| $1.45M | ﹤0.01% |
72,356
+2,423
| +3% | +$48.9K |
|
3004
Gencor Industries
GENC
$217M
| $1.45M | ﹤0.01% |
114,560
+5,197
| +5% | +$60.1K |
|
3005
C&F Financial
CFFI
$273M
| $1.45M | ﹤0.01% |
43,510
+884
| +2% | +$30.3K |
|
|
RJET
3006
Republic Airways Holdings
RJET
$1.01B
| $1.44M | ﹤0.01% |
27,950
+1,814
| +7% | +$96.1K |
|
3007
Concrete Pumping Holdings
BBCP
$495M
| $1.44M | ﹤0.01% |
414,341
+69,113
| +20% | +$211K |
|
3008
BGSF Inc
BGSF
$60.3M
| $1.44M | ﹤0.01% |
126,928
+2,818
| +2% | +$28.8K |
|
3009
AdaptHealth
AHCO
$1.51B
| $1.43M | ﹤0.01% |
+88,638
| New | +$1.48M |
|
3010
Savara
SVRA
$1.11B
| $1.43M | ﹤0.01% |
572,764
+94,462
| +20% | +$230K |
|
|
XONE
3011
DELISTED
The ExOne Company
XONE
| $1.43M | ﹤0.01% |
166,804
+78,678
| +89% | +$626K |
|
3012
Gyre Therapeutics
GYRE
$670M
| $1.42M | ﹤0.01% |
32,321
+16,499
| +104% | +$775K |
|
3013
Research Frontiers
REFR
$15.6M
| $1.42M | ﹤0.01% |
349,598
+164,987
| +89% | +$612K |
|
|
ETNB
3014
DELISTED
89bio
ETNB
| $1.41M | ﹤0.01% |
70,954
+1,952
| +3% | +$47.4K |
|
3015
Organogenesis Holdings
ORGO
$306M
| $1.41M | ﹤0.01% |
368,263
+126,158
| +52% | +$455K |
|
3016
Franklin Financial Services
FRAF
$282M
| $1.41M | ﹤0.01% |
54,572
+1,716
| +3% | +$44.4K |
|
3017
Chemung Financial Corp
CHMG
$397M
| $1.41M | ﹤0.01% |
51,602
+598
| +1% | +$15.8K |
|
3018
Genmab
GMAB
$17.5B
| $1.41M | ﹤0.01% |
41,524
+12,361
| +42% | +$337K |
|
|
MPX
3019
DELISTED
Marine Products Corp
MPX
| $1.41M | ﹤0.01% |
101,591
+4,195
| +4% | +$44K |
|
|
PINE
3020
Alpine Income Property Trust
PINE
$334M
| $1.41M | ﹤0.01% |
+86,572
| New | +$1.12M |
|
3021
National Grid
NGG
$80B
| $1.39M | ﹤0.01% |
25,918
-3,787
| -13% | -$192K |
|
3022
SB Financial Group
SBFG
$165M
| $1.38M | ﹤0.01% |
87,351
+48,793
| +127% | +$702K |
|
|
DZSI
3023
DELISTED
DZS Inc. Common Stock
DZSI
| $1.38M | ﹤0.01% |
154,320
+38,020
| +33% | +$254K |
|
3024
Mustang Bio
MBIO
$4.37M
| $1.37M | ﹤0.01% |
576
+35
| +6% | +$81.8K |
|
3025
VolitionRx Ltd
VNRX
$9.4M
| $1.37M | ﹤0.01% |
17,651
+7,409
| +72% | +$535K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.